119 related articles for article (PubMed ID: 38923907)
41. Geometric and dosimetric uncertainties in intracranial stereotatctic treatments for multiple nonisocentric lesions.
Winey B; Bussiere M
J Appl Clin Med Phys; 2014 May; 15(3):122–132. PubMed ID: 24892339
[TBL] [Abstract][Full Text] [Related]
42. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
43. Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
Jaccard M; Zilli T; Dubouloz A; Escude L; Jorcano S; Linthout N; Bral S; Verbakel W; Bruynzeel A; Björkqvist M; Minn H; Tsvang L; Symon Z; Lencart J; Oliveira A; Ozen Z; Abacioglu U; Pérez-Moreno JM; Rubio C; Rouzaud M; Miralbell R
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1047-1054. PubMed ID: 32535161
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
45. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
[TBL] [Abstract][Full Text] [Related]
46. Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?
Byun DJ; Gorovets DJ; Jacobs LM; Happersett L; Zhang P; Pei X; Burleson S; Zhang Z; Hunt M; McBride S; Kollmeier MA; Zelefsky MJ
Radiat Oncol; 2020 Oct; 15(1):239. PubMed ID: 33066781
[TBL] [Abstract][Full Text] [Related]
47. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.
Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F
Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794
[TBL] [Abstract][Full Text] [Related]
48. Validation of dynamic treatment-couch tracking for prostate SBRT.
Ehrbar S; Schmid S; Jöhl A; Klöck S; Guckenberger M; Riesterer O; Tanadini-Lang S
Med Phys; 2017 Jun; 44(6):2466-2477. PubMed ID: 28339109
[TBL] [Abstract][Full Text] [Related]
49. Testicular doses in image-guided radiotherapy of prostate cancer.
Deng J; Chen Z; Yu JB; Roberts KB; Peschel RE; Nath R
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e39-47. PubMed ID: 21489702
[TBL] [Abstract][Full Text] [Related]
50. Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking.
Jaccard M; Ehrbar S; Miralbell R; Hagen T; Koutsouvelis N; Poulsen P; Rouzaud M; Tanadini-Lang S; Tsoutsou P; Guckenberger M; Zilli T
Radiother Oncol; 2021 Mar; 156():145-152. PubMed ID: 33310011
[TBL] [Abstract][Full Text] [Related]
51. Prostate SBRT With Intrafraction Motion Management Using a Novel Linear Accelerator-Based MV-kV Imaging Method.
Gorovets D; Burleson S; Jacobs L; Ravindranath B; Tierney K; Kollmeier M; McBride S; Happersett L; Hunt M; Zelefsky M
Pract Radiat Oncol; 2020; 10(5):e388-e396. PubMed ID: 32454176
[TBL] [Abstract][Full Text] [Related]
52. Optimization and quality assurance of an image-guided radiation therapy system for intensity-modulated radiation therapy radiotherapy.
Tsai JS; Micaily B; Miyamoto C
Med Dosim; 2012; 37(3):321-33. PubMed ID: 22417899
[TBL] [Abstract][Full Text] [Related]
53. The first clinical implementation of a real-time six degree of freedom target tracking system during radiation therapy based on Kilovoltage Intrafraction Monitoring (KIM).
Nguyen DT; O'Brien R; Kim JH; Huang CY; Wilton L; Greer P; Legge K; Booth JT; Poulsen PR; Martin J; Keall PJ
Radiother Oncol; 2017 Apr; 123(1):37-42. PubMed ID: 28342648
[TBL] [Abstract][Full Text] [Related]
54. Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment.
Bell LJ; Eade T; Kneebone A; Hruby G; Alfieri F; Bromley R; Grimberg K; Barnes M; Booth JT
J Med Radiat Sci; 2017 Mar; 64(1):25-34. PubMed ID: 28263041
[TBL] [Abstract][Full Text] [Related]
55. Volumetric-based image guidance is superior to marker-based alignments for stereotactic body radiotherapy of prostate cancer.
Li W; Lu L; Stephans KL; Sharma N; Vassil A; Shen ZL; Stockham A; Djemil T; Tendulkar RD; Xia P
J Appl Clin Med Phys; 2018 Mar; 19(2):198-203. PubMed ID: 29450961
[TBL] [Abstract][Full Text] [Related]
56. Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.
Sheng Y; Li T; Lee WR; Yin FF; Wu QJ
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):473-480. PubMed ID: 28463167
[TBL] [Abstract][Full Text] [Related]
57. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
[TBL] [Abstract][Full Text] [Related]
58. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
[TBL] [Abstract][Full Text] [Related]
59. To frame or not to frame? Cone-beam CT-based analysis of head immobilization devices specific to linac-based stereotactic radiosurgery and radiotherapy.
Babic S; Lee Y; Ruschin M; Lochray F; Lightstone A; Atenafu E; Phan N; Mainprize T; Tsao M; Soliman H; Sahgal A
J Appl Clin Med Phys; 2018 Mar; 19(2):111-120. PubMed ID: 29363282
[TBL] [Abstract][Full Text] [Related]
60. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
Dubouloz A; Rouzaud M; Tsvang L; Verbakel W; Björkqvist M; Linthout N; Lencart J; Pérez-Moreno JM; Ozen Z; Escude L; Zilli T; Miralbell R
Radiat Oncol; 2018 Jun; 13(1):114. PubMed ID: 29921291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
